Clinical Impact of New HIV Data From EACS 2021*

Download All
October 27-30, 2021; London, United Kingdom
Get the latest data from EACS 2021 on practical management strategies and the latest data for HIV. Explore key studies from this important international conference in the on-demand webinars, Capsule Summaries, and ClinicalThought expert commentaries. Share the downloadable slidesets with colleagues.
person default
Tristan J. Barber, MA, MD, FRCP
Monica Gandhi, MD, MPH
Juan Luis Mosqueda Gomez, MD, MSc
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Jürgen K. Rockstroh, MD
Prof. Don Smith
Babafemi Taiwo, MBBS
Darrell H. S. Tan, MD, FRCPC, PhD
person default
Yan Zhao, MD

Highlights

Dr Babafemi Taiwo, MBBS, recaps key studies on HIV drug resistance from EACS 2021.

Babafemi Taiwo, MBBS Released: November 23, 2021

Here’s how the IMEA 055 FAST study of BIC/FTC/TAF in a test-and-treat model fits with our approach at Ward 86.

Monica Gandhi, MD, MPH Released: December 1, 2021

Listen to expert insights from Tristan J. Barber, MA, MD, FRCP, on some of the most clinically relevant new data presented at EACS 2021, including first-line, switch, and long-acting ART, the efficacy of COVID-19 vaccinations in PWH, and more.

person default Tristan J. Barber, MA, MD, FRCP Released: November 30, 2021

Read expert faculty members’ summaries of key studies from EACS 2021, including results from studies on BIC/FTC/TAF in a test-and-treat model; islatravir and doravirine in treatment naïve patients; DTG/3TC in patients with an M184V mutation; long-acting CAB + RPV by BMI category, patient satisfaction, and outcomes after discontinuation; lenacapavir in heavily treatment experienced patients; and COVID-19 vaccine effectiveness and the impact of the pandemic on virologic suppression in PWH.

person default Tristan J. Barber, MA, MD, FRCP Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Jürgen K. Rockstroh, MD Released: November 15, 2021

Hear from CCO’s expert faculty, Dr. Chloe Orkin, as she presents her insights on some of the most clinically relevant new data presented at EACS 2021, including first-line, switch, and long-acting ART, the efficacy of COVID-19 vaccinations, and more.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: November 17, 2021

Hear from expert faculty as he presents his unique insights on some of the most clinically relevant new data presented at EACS 2021, including first-line, switch, and long-acting ART, the efficacy of COVID-19 vaccinations in PWH, and more.

Jürgen K. Rockstroh, MD Released: November 19, 2021

Hear from expert faculty as he presents his unique insights on some of the most clinically relevant new data presented at EACS 2021, including first-line, switch, and long-acting ART, the efficacy of COVID-19 vaccinations in PWH, and more.

person default Tristan J. Barber, MA, MD, FRCP Released: November 22, 2021

Global Perspectives

Here’s why I’m concerned by data on rates of virologic suppression in Europe.

person default Tristan J. Barber, MA, MD, FRCP Released: November 22, 2021

Here’s why we should be loudly and publicly promoting PrEP as a healthy choice for all those at risk for HIV.

Darrell H. S. Tan, MD, FRCPC, PhD Released: November 19, 2021

Use of long-acting antiretroviral therapy represents a quantum shift in HIV management due to its potent, sustainable effects.

Prof. Don Smith Released: November 23, 2021

My thoughts on the implications of the IMEA 055 FAST study data presented at EACS 2021 for linkage to care among PWH in Latin America.

Juan Luis Mosqueda Gomez, MD, MSc Released: December 1, 2021

New data from EACS 2021 highlight the unique challenges of older people living with HIV, particularly those living in the Asia-Pacific region.

person default Yan Zhao, MD Released: November 30, 2021

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue